Evidence map›Paper›PMID 30124472›Full record

ReviewCurrent opinion in gastroenterology2018

Duodenal chemosensing.

Mari Iwasaki, Yasutada Akiba, Jonathan D Kaunitz

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mari IwasakiVeterans Affair Greater Los Angeles Healthcare System.
Yasutada AkibaVeterans Affair Greater Los Angeles Healthcare System.
Jonathan D KaunitzVeterans Affair Greater Los Angeles Healthcare System.
VA Greater Los Angeles Healthcare System · USUniversity of California, Los Angeles · US

Funding

Duodenal Muscosal Defense MechanismsR01DK054221 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KAUNITZ, JONATHAN D. · 1999 to 2016
$4.4M
Luminal Factors Affecting Duodenal Protection and ChemosensingI01BX001245 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI KAUNITZ, JONATHAN D. · 2012 to 2025
–
BLRD VA I01 BX001245NIDDK NIH HHS R01 DK054221
6 · The paper itself

Abstract

purpose of reviewLuminal chemosensing is a term used to describe how small molecules in the gut lumen interact with the host through surface receptors or via transport into the submucosa. In this review, we have summarized recent advances of understanding luminal chemosensing in the gastroduodenal mucosa, with a particular emphasis on how chemosensing affects mucosal protective responses and the metabolic syndrome. RECENT

findingsIn the past decade, data have supported the hypothesis that gut luminal chemosensing not only is important for the local or remote regulation of gut function but also contributes to the systemic regulation of metabolism, energy balance and food intake. We have provided examples of how luminal nutrients such as long-chain fatty acids (LCFAs), endogenous compounds such as bile acids, bacterial metabolites such as short-chain fatty acids (SCFAs) and bacterial components such as lipopolysaccharide (LPS) activate cognate receptors expressed on key effector cells such as enteroendocrine cells and inflammatory cells in order to profoundly affect organ function through the initiation or suppression of inflammatory pathways, altering gut barrier function and nutrient uptake, altering gut motility and visceral pain pathways, and preventing mucosal injury. SUMMARY: These recent discoveries in this area have provided new possibilities for identifying novel molecular targets for the treatment of mucosal injury, metabolic disorders and abnormal visceral sensation. Understanding luminal chemosensory mechanisms may help to identify novel molecular targets for the treatment and prevention of mucosal injury, metabolic disorders and abnormal visceral sensation.

Indexed as

Alkaline PhosphataseChemoreceptor CellsDuodenumFatty AcidsGPI-Linked ProteinsHumansIntestinal MucosaLipopolysaccharidesNutrientsReceptors, G-Protein-CoupledAlkaline PhosphataseALPI protein, humanFatty AcidsGPI-Linked ProteinsLipopolysaccharidesNutrientsReceptors, G-Protein-Coupled

Identifiers

PMID30124472
PMCPMC7193725
OpenAlexW4240894030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.